Axsome Therapeutics Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Axsome Therapeutics heeft een totaal eigen vermogen van $92.9M en een totale schuld van $180.0M, wat de schuld-eigenvermogensverhouding op 193.8% brengt. De totale activa en totale passiva bedragen respectievelijk $561.5M en $468.6M.
Belangrijke informatie
193.8%
Verhouding schuld/eigen vermogen
US$180.00m
Schuld
Rente dekkingsratio | n/a |
Contant | US$327.34m |
Aandelen | US$92.90m |
Totaal verplichtingen | US$468.56m |
Totaal activa | US$561.46m |
Recente financiële gezondheidsupdates
Does Axsome Therapeutics (NASDAQ:AXSM) Have A Healthy Balance Sheet?
Nov 25Health Check: How Prudently Does Axsome Therapeutics (NASDAQ:AXSM) Use Debt?
Jul 02Does Axsome Therapeutics (NASDAQ:AXSM) Have A Healthy Balance Sheet?
Mar 17Is Axsome Therapeutics (NASDAQ:AXSM) Using Debt In A Risky Way?
Dec 12Is Axsome Therapeutics (NASDAQ:AXSM) Using Debt In A Risky Way?
Sep 12Is Axsome Therapeutics (NASDAQ:AXSM) Using Debt Sensibly?
Mar 01Recent updates
Axsome: Focus On AXS-12 Targeting Narcolepsy, Which Just Released Positive Data
Nov 29Does Axsome Therapeutics (NASDAQ:AXSM) Have A Healthy Balance Sheet?
Nov 25Axsome Therapeutics Q3 Earnings: Stay For The Near Term Catalysts, Then Sell
Nov 12Axsome: AXS-07 And Its Upcoming Second PDUFA
Oct 15Getting In Cheap On Axsome Therapeutics, Inc. (NASDAQ:AXSM) Might Be Difficult
Sep 06Axsome's Auvelity: High Hopes Meet Hefty Bills (Rating Downgrade)
Aug 06Axsome Therapeutics: Lots Of Moving Parts
Jul 23Health Check: How Prudently Does Axsome Therapeutics (NASDAQ:AXSM) Use Debt?
Jul 02Why Axsome Therapeutics Is A Promising Stock Pick In CNS Treatments
May 10Axsome Therapeutics, Inc. (NASDAQ:AXSM) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 09Axsome Therapeutics, Inc.'s (NASDAQ:AXSM) Price In Tune With Revenues
Apr 13Does Axsome Therapeutics (NASDAQ:AXSM) Have A Healthy Balance Sheet?
Mar 17Axsome: Unpacking Auvelity's First-Year Market Dynamics And Economic Challenges
Feb 21Axsome Therapeutics, Inc.'s (NASDAQ:AXSM) P/S Is Still On The Mark Following 27% Share Price Bounce
Dec 27Is Axsome Therapeutics (NASDAQ:AXSM) Using Debt In A Risky Way?
Dec 12Is Axsome Therapeutics (NASDAQ:AXSM) Using Debt In A Risky Way?
Sep 12Axsome Therapeutics, Inc.'s (NASDAQ:AXSM) Price In Tune With Revenues
Aug 08Upgrade: Analysts Just Made A Dazzling Increase To Their Axsome Therapeutics, Inc. (NASDAQ:AXSM) Forecasts
May 13Earnings Update: Axsome Therapeutics, Inc. (NASDAQ:AXSM) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts
Mar 03Is Axsome Therapeutics (NASDAQ:AXSM) Using Debt Sensibly?
Mar 01Is Axsome Therapeutics (NASDAQ:AXSM) Weighed On By Its Debt Load?
Nov 14Axsome Therapeutics: Clear Path Ahead For AXS07
Oct 05Axsome to resubmit marketing application for migraine therapy in Q3 2023
Sep 29Axsome: In The Middle Of Uncertainty Is Your Biggest Opportunity
Sep 16Axsome begins enrolling in late-stage study of migraine drug AXS-07
Sep 01Axsome gains 19% as FDA approves depression therapy
Aug 19Axsome Therapeutics Q2 2022 Earnings Preview
Aug 08Axsome: Breaking Bearish Trend
Jul 26Axsome: One Step At A Time
Jul 01Axsome And AXS-05: A Special Situation
May 02Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $479.1M ) AXSM } overtreffen de korte termijn passiva ( $196.2M ).
Langlopende schulden: De kortetermijnactiva AXSM ( $479.1M ) overtreffen de langetermijnschulden ( $272.4M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: AXSM heeft meer geld in kas dan de totale schuld.
Schuld verminderen: De schuld/eigen vermogen-ratio van AXSM is de afgelopen 5 jaar gedaald van 289.6% naar 193.8%.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: AXSM heeft op basis van de huidige vrije kasstroom voldoende kasstroom voor meer dan een jaar.
Voorspelling contante baan: Er zijn onvoldoende gegevens om te bepalen of AXSM voldoende cash runway heeft als de vrije kasstroom blijft groeien of krimpen op basis van historische percentages.